-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
January 01, 2014 - Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST
Elevation Myo…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
July 01, 2012 - Methods Guide for Medical Test Reviews Chapter 12
12-1
Chapter 12
Systematic Review of Prognostic Tests
Thomas S. Rector, Ph.D.; Brent C. Taylor, Ph.D.; Timothy J. Wilt, M.D., M.P.H.
Minneapolis Veterans Affairs Health Care System;
School of Medicine, University of Minnesota,
Minneapolis, MN
Abstra…
-
effectivehealthcare.ahrq.gov/products/restless-legs/research-protocol
December 16, 2011 - sleep breathing disorders
Pittsburgh Sleep Quality Index
Measures multiple aspects of sleep to calculate
-
effectivehealthcare.ahrq.gov/sites/default/files/s38.pdf
October 01, 2007 - To estimate �, we calculate the
between mean square (BMS) as BMS � �
i�1
k m�y�i � y��
2/
�k � 1�,
-
effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
October 01, 2007 - series of generalized linear
models to estimate the parameters of the outcome proba-
bility models, and calculate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
December 01, 2012 - for all subjects, if
the imaging techniques were not adequately described, or
if relevant data to calculate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
February 01, 2012 - surrogate for a screening population
with prevalent cancer, i.e., a valid surrogate from which to
calculate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
April 01, 2013 - For categorical
variables, we abstracted the number of events among
treatment groups to calculate rates … We abstracted means and
standard deviations of continuous variables to calculate
mean differences with … We abstracted the number randomized to each treatment
group as the denominator to calculate estimates
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-32-pharm-non-pharm-ptsd.pdf
May 14, 2019 - I think it
would be worthwhile to calculate the effect sizes from the
information provided in the papers
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
November 28, 2023 - model in Comprehensive Meta-Analysis version 3 (Biostat, Englewood, New Jersey) or
R.26 We will calculate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
December 08, 2014 - • For comparative accuracy (part of KQ1), this means reporting enough
information for one to calculate … For Key Question 3 on patient factors and tumor characteristics, we will calculate for
each study the … This ratio can be applied
to the pretest probability of disease to calculate the posttest probability … This ratio can be
applied to the pretest probability of disease to calculate the posttest probability
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
January 01, 2011 - Incidence of diabetic foot ulcer and lower extremity
amputation among Medicare beneficiaries,
2006 to 2008
Diabetic Foot Ulcers Data Points #2
In Medicare Parts A and B fee-for-
service beneficiaries with diabetes, the
incidence of diabetic foot ulcer is about
6.0% and lower extremity amputation
about 0.5%.
Am…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
October 30, 2012 - 71
Abstract
This chapter provides an overview of considerations for the development of outcome measures
for observational comparative effectiveness research (CER) studies, describes implications of the
proposed outcomes for study design, and enumerates issues of bias that may arise in incorporating the
ascertainme…
-
effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/research-protocol
June 23, 2014 - Using a random effects model, we will calculate risk ratios (RR) and absolute risk differences (RD) with … available, we will use a statistical difference to assess efficacy and comparative effectiveness and calculate … We will calculate MID for outcomes for which strength of evidence is assessed.
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-2.xlsx
March 01, 2020 - B-2. Obs Studs Masks Community
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table A-2. Observational Studies of Masks in the Community
Virus Strain Author Publication Year Title Date Retrieved Source Link/URL Study Desig…
-
effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-2-surveillance-report.xlsx
March 01, 2020 - B-2. Obs Studs Masks Community
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-2. Observational Studies of Masks in the Community
Virus Strain Author Publication Year Title Date Retrieved Source Link/URL Study Desig…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
January 01, 2007 - PHS 398 (Rev. 9/04), Continuation Page
Award: CERTs Comparative Effectiveness Supplement (U18HS010399-06S1)
Project Title: Validation of Outcomes in Centers for Medicare & Medicaid Services (CMS) Data
Principal Investigator: Brian L. Strom, MD, MPH
Co-Principal Investigator: Sean Hennessy, PharmD…
-
effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
January 01, 2005 - PHS 398 (Rev. 9/04), Continuation Page
Award: CERTs Comparative Effectiveness Supplement (U18HS010399-06S1)
Project Title: Validation of Outcomes in Centers for Medicare & Medicaid Services (CMS) Data
Principal Investigator: Brian L. Strom, MD, MPH
Co-Principal Investigator: Sean Hennessy, PharmD…
-
effectivehealthcare.ahrq.gov/products/heart-failure-natriuretic-peptide/research-protocol
December 20, 2011 - No gold standard diagnostic criteria exist in HF, so we will calculate sensitivity and specificity of … regarding the reference standard, test performance characteristics (either primary data to allow us to calculate … sample collection parameters (e.g., tube type, handling, processing, storage);statistical methods to calculate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
June 01, 2018 - percent will be considered to indicate substantial
heterogeneity.22
For continuous outcomes, we will calculate … with appropriate analyses when there is higher heterogeneity.24 For
dichotomous outcomes, we will calculate